Dr Yvonne Katterle, Head of Bioanalytics at Bayer presented an update on her ARDAT work on the “Strengths and weaknesses of different ligand binding assay formats for the determination of anti-AAV9 antibodies” at the 17th EBF Open Symposium in Barcelona, Spain 20-22nd November 2024.